Type II & III inhibitors of tropomyosin receptor kinase (Trk): a 2020-2022 patent update
{{output}}
Introduction: The Trk family proteins are membrane-bound kinases predominantly expressed in neuronal tissues. Activated by neurotrophins, they regulate critical cellular processes through downstream signaling pathways. Dysregulat... ...